Ftse Mib
33.736,40
0,00%
DAX
17.896,50
-0,14%
S&P 500
5.064,20
0,91%
NASDAQ
15.840,96
1,51%
Bitcoin
59.374,68
0,43%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Kintara Therapeutics Inc (KTRA) Kintara Therapeutics Inc (KTRA) Notizie

Kintara Therapeutics Inc

KTRA
0,155
0,007 (4,73%)
03 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
05/4/202419:09PRNUSKuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to..
03/4/202413:00PRNUSKintara Therapeutics and TuHURA Biosciences Enter into..
27/3/202414:00PRNUSKintara Therapeutics Announces Expansion of REM-001 Clinical..
27/2/202412:59EDGAR2Form 8-K - Current report
26/2/202413:00EDGAR2Form 8-K - Current report
22/2/202413:00EDGAR2Form 8-K - Current report
14/2/202422:07PRNUSKintara Therapeutics Announces Fiscal 2024 Second Quarter..
12/2/202415:05EDGAR2Form 8-K - Current report
12/2/202415:00PRNUSKintara Therapeutics Announces Initiation of REM-001..
18/12/202322:10EDGAR2Form 8-K - Current report
18/12/202322:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
15/12/202322:15EDGAR2Form 8-K - Current report
07/12/202315:10EDGAR2Form 8-K - Current report
07/12/202315:00PRNUSKintara Therapeutics Announces Review of Strategic..
05/12/202315:10EDGAR2Form 8-K - Current report
05/12/202315:00PRNUSKintara Therapeutics Granted Extension by Nasdaq to Regain..
21/11/202313:55EDGAR2Form 8-K - Current report
13/11/202322:15EDGAR2Form 8-K - Current report
13/11/202322:10PRNUSKintara Therapeutics Announces Fiscal 2024 First Quarter..
13/11/202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/10/202313:10EDGAR2Form 8-K - Current report
31/10/202313:00PRNUSKintara Therapeutics Announces Preliminary Topline Results..
27/10/202322:05EDGAR2Form S-1/A - General form for registration of securities..
24/10/202322:43EDGAR2Form S-1/A - General form for registration of securities..
10/10/202322:06EDGAR2Form 8-K - Current report
04/10/202322:35EDGAR2Form S-1 - General form for registration of securities under..
26/9/202322:09EDGAR2Form 8-K - Current report
21/9/202315:35GLOBEDawson James Securities Announces October Date for 8th..
19/9/202322:20EDGAR2Form 8-K - Current report
19/9/202322:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
18/9/202322:31EDGAR2Form 8-K - Current report
18/9/202322:25EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
11/9/202322:06EDGAR2Form DEF 14A - Other definitive proxy statements
02/9/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/9/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/9/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/9/202322:05EDGAR2Form PRE 14A - Other preliminary proxy statements
30/6/202323:11EDGAR2Form 8-K - Current report
Apertura: 0,1472 Min: 0,145 Max: 0,1617
Chiusura: 0,148

La tua Cronologia

NASDAQ
KTRA
Kintara Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network